Codes / CPT4 / 86337

86337 Insulin antibodies

CPT4 code

CPT4

Chat with GenHealth to automate any coding or chart task.

Answer first

What does 86337 mean for coverage and prior authorization?

86337 is a CPT4 code for Insulin antibodies. Coverage and prior authorization can vary by payer, plan, diagnosis, place of service, and documentation, so teams should connect the code to the current payer policy before acting.

CPT4 reference
Review with confidence

Apply current policy criteria

Connect codes, payer policy, documentation, and cited criteria before work moves forward.

Explore policy intelligence
Handle the admin work

Automate prior authorization

Turn requirements into intake, submission, status checks, and follow-up across existing systems.

See prior auth automation
Get paid

Carry clean work into RCM

Automate billing, denials, posting, and A/R work without adding another queue for your team.

See RCM automation

This page is an operational reference, not medical or legal advice. Payer requirements change; verify current plan rules and patient-specific facts.

Name of the Procedure:

Insulin Antibody Test
Common name(s): Insulin Autoantibody Test

Summary

The Insulin Antibody Test is a blood test used to detect antibodies against insulin. This procedure helps determine if a person has an autoimmune reaction to insulin.

Purpose

The Insulin Antibody Test is primarily used to diagnose autoimmune diabetes, such as Type 1 diabetes. It helps to identify if the body's immune system is attacking insulin, which is crucial for developing appropriate treatment plans.

Indications

  • Sudden onset of high blood sugar levels
  • Symptoms of diabetes, such as frequent urination, excessive thirst, and unexplained weight loss
  • Family history of autoimmune diseases
  • Diagnosis of diabetes in children and young adults

Preparation

  • Generally, no special preparation is required.
  • Patients may need to provide information about their current medications.
  • It’s advisable to inform the healthcare provider about any allergies or medical conditions.

Procedure Description

  1. Blood Sample Collection:
    • A healthcare professional will clean the skin with an antiseptic.
    • An elastic band is placed around the upper arm to fill the veins with blood.
    • A needle is inserted into a vein to draw blood into a vial.
  2. The blood sample is sent to a laboratory for analysis to detect the presence of insulin antibodies.

Duration

The blood draw itself typically takes about 5 to 10 minutes. Results from the lab may take a few days to a week.

Setting

This test is usually performed in a healthcare provider’s office, outpatient clinic, or laboratory.

Personnel

  • Phlebotomist or nurse to collect the blood sample.
  • Laboratory technicians to analyze the sample.
  • Endocrinologist or general physician to interpret the results.

Risks and Complications

  • Minor bruising or bleeding at the site of needle insertion
  • Rare risk of infection
  • Fainting or feeling lightheaded

Benefits

  • Accurate diagnosis of autoimmune diabetes.
  • Helps in developing personalized treatment plans.
  • Allows for better management of diabetes and prevention of complications.

Recovery

  • Little to no recovery time needed.
  • Patients can resume normal activities immediately after the blood draw.
  • Follow-up appointment may be required to discuss test results and next steps.

Alternatives

  • C-peptide test: Measures the production of insulin.
  • Glutamic acid decarboxylase (GAD) antibody test: Another autoimmune marker for diabetes.
  • Each alternative has its own specificity and sensitivity, but the Insulin Antibody Test is specifically for autoimmune insulin detection.

Patient Experience

During the procedure, the patient may feel a slight pinch when the needle is inserted. Post-procedure, some slight bruising or tenderness at the site may occur but usually resolves quickly. Comfort measures like cold packs and over-the-counter pain relievers can help manage any discomfort.

Turn the reference into work

Automate the next step for 86337

See how GenHealth connects policy review to documentation, prior authorization, billing, and follow-up across the systems your team already uses.